Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02159521 · ClinicalTrials.gov registry record · Phase 4
Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT02159521 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 81 participants.
The verdict
NCT02159521, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome from chronic venous occlusion.
Interventions
- BIOLOGICAL Alteplase
- DEVICE EkoSonic® Endovascular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2014-07-10 |
| Est. Completion | 2017-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02159521
The ClinicalTrials.gov registry entry for NCT02159521 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alteplase is the first listed.
NCT02159521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02159521 about?
NCT02159521 is a clinical study titled "Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System". To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome from chronic venous occlusion.
What is the current status of trial NCT02159521?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2014-07-10. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT02159521?
The interventions under investigation include: Alteplase (BIOLOGICAL), EkoSonic® Endovascular System (DEVICE).
Who is sponsoring clinical trial NCT02159521?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.